Trinity Biotech plc announced the appointment of Mr. Tom Lindsay to its Board of Directors as an independent non-executive director.Mr Lindsay is an experienced diagnostic leader and brings to Trinity Biotech more than 35 years of sales and marketing leadership experience in the global diagnostics industry. He also has significant experience in point of care diagnostics and global health initiatives having been President of Alere Inc.'s (now Abbotts's) business in Africa for many years. Most recently, Mr. Lindsay has provided consultancy services to a number of international in vitro diagnostics businesses.

Mr. Lindsay currently also serves as a non-executive director for Genedrive plc, a rapid, ow-cost molecular diagnostics platform for the identification and treatment of a selection of infectious diseases. Non-executive directors Mr. Seon Kyu Jeon and Mr. Michael Sung Soo Kim have now left the Trinity Biotech plc Board of Directors.